Literature DB >> 25253682

Comment on: "Are current cost-effectiveness thresholds for low- and middle-income countries useful? Examples from the world of vaccines".

Afschin Gandjour1.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25253682     DOI： 10.1007/s40273-014-0221-3

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  7 in total

1.  Demography. Broken limits to life expectancy.

Authors:  Jim Oeppen; James W Vaupel
Journal:  Science       Date:  2002-05-10       Impact factor: 47.728

2.  Cost-effectiveness analysis and innovation.

Authors:  Anupam B Jena; Tomas J Philipson
Journal:  J Health Econ       Date:  2008-06-05       Impact factor: 3.883

3.  [Comments by the Working Group for Methods of Economic Evaluation in Health Care (AG MEG) to IQWiG's Draft Guidelines "Methods for Assessment of the Relation of Benefits to Costs in the German Statutory Health Care System"].

Authors:  C Krauth; J John; P Aidelsburger; B Brüggenjürgen; T Hansmeier; F Hessel; T Kohlmann; J Moock; H Rothgang; B Schweikert; R Seitz; J Wasem
Journal:  Gesundheitswesen       Date:  2008-06

4.  Germany's decision rule for setting ceiling prices of drugs: a comparative analysis with other decision rules.

Authors:  Afschin Gandjour
Journal:  Appl Health Econ Health Policy       Date:  2011-03-01       Impact factor: 2.561

5.  The German method for setting ceiling prices for drugs: in some cases less data are required.

Authors:  Afschin Gandjour; Amiram Gafni
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2011-08       Impact factor: 2.217

6.  Are current cost-effectiveness thresholds for low- and middle-income countries useful? Examples from the world of vaccines.

Authors:  A T Newall; M Jit; R Hutubessy
Journal:  Pharmacoeconomics       Date:  2014-06       Impact factor: 4.981

7.  Drug pricing and control of health expenditures: a comparison between a proportional decision rule and a cost-per-QALY rule.

Authors:  Afschin Gandjour
Journal:  Int J Health Plann Manage       Date:  2014-05-01
  7 in total
  2 in total

1.  Comment on: "Healthy Decisions: Towards Uncertainty Tolerance in Healthcare Policy".

Authors:  Afschin Gandjour
Journal:  Pharmacoeconomics       Date:  2015-09       Impact factor: 4.981

2.  Authors' reply to Gandjour: "Are current cost-effectiveness thresholds for low- and middle-income countries useful? Examples from the world of vaccines".

Authors:  A T Newall; M Jit; R Hutubessy
Journal:  Pharmacoeconomics       Date:  2014-12       Impact factor: 4.981
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.